Alzheimer's disease is a progressive brain disorder that affects memory, thinking, and behavior, impacting over 6 million people in the United States alone. It is the most common cause of dementia, accounting for 60-80% of all dementia cases, and it severely impairs the ability to carry out daily activities as it advances. In Alzheimer’s disease, abnormal protein deposits—amyloid plaques and tau tangles—accumulate in the brain, disrupting neural connections and causing brain cells to degenerate and die. Although the risk of Alzheimer's increases with age, with most cases occurring in individuals over 65, it is not a normal part of aging. Early symptoms may include forgetfulness or mild confusion, which over time progress to serious memory loss, disorientation, and challenges with communication and self-care. Alzheimer's research continues to focus on early detection, prevention, and treatments to improve quality of life and slow the disease’s progression, with promising advances in both diagnostics and therapy.

​

​

​The San Diego Alzheimer's Disease Resource Center for Minority Aging Research (SD AD-RCMAR) is dedicated to advancing our understanding of Alzheimer's, particularly in minority and underrepresented aging communities, who may face unique challenges related to the disease. Through research, education, and community engagement, SD AD-RCMAR aims to improve detection, prevention, and treatment strategies, supporting healthier aging for all communities.

​

​

​